Christopher Plescia
Impact in
- Biotechnology top 5%
- Cancer Research and Treatments
-
- interferon and immune responses
- Immunotherapy and Immune Responses
Papers in
-
- Cancer-related gene regulation 3
- Epigenetics and DNA Methylation 2
- RNA modifications and cancer 2
- Chromatin Remodeling and Cancer 1
- CRISPR and Genetic Engineering 1
- Co-authors
- Daniel S. Leventhal (1 shared paper)Ning Li (1 shared paper)José M. Lora (1 shared paper)Starsha Kolodziej (1 shared paper)Adam Fisher (1 shared paper)Anna Sokolovska (1 shared paper)Munira Momin (1 shared paper)Rudy Christmas (1 shared paper)
- Journals
- Molecular Cancer Therapeutics (3 papers)Journal of Clinical Oncology (2 papers)Nature Communications (1 paper)Differentiation (1 paper)
- Partner nations
- United States
In The Last Decade
Christopher Plescia
6 papers receiving 439 citations
Christopher Plescia's Hit Papers
Peers
Comparison fields: 5 of 51
- Biotechnology 182
- Immunology 100
- Biological Psychiatry 8
- Biomedical Engineering 142
- Oncology 72
Countries citing papers authored by Christopher Plescia
This map shows the geographic impact of Christopher Plescia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Plescia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Plescia more than expected).
Fields of papers citing papers by Christopher Plescia
This network shows the impact of papers produced by Christopher Plescia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Plescia. The network helps show where Christopher Plescia may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher Plescia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Immunotherapy with engineered bacteria by targeting the STING pathway for anti-tumor immunity Hit paper breakdown → | 2020 | 344 |
| 2 | 2017 | 52 | |
| 3 | 2001 | 40 | |
| 4 | 2024 | 6 | |
| 5 | 2021 | 3 | |
| 6 | 2015 | 3 | |
| 7 | 2015 | 1 |
About Christopher Plescia
Christopher Plescia is a scholar working on Molecular Biology, Epidemiology, Genetics, Infectious Diseases and Surgery, having authored 7 papers that have together received 449 indexed citations. Recurring topics across this work include Cancer-related gene regulation (3 papers), Epigenetics and DNA Methylation (2 papers), RNA modifications and cancer (2 papers), Virus-based gene therapy research (2 papers), Chromatin Remodeling and Cancer (1 paper), Cancer Research and Treatments (1 paper), CRISPR and Genetic Engineering (1 paper) and Immunotherapy and Immune Responses (1 paper). The work is most often cited by research in Biotechnology (182 citations), Immunology (100 citations), Biological Psychiatry (8 citations), Biomedical Engineering (142 citations) and Oncology (72 citations). Christopher Plescia has collaborated with scholars based in United States. Frequent co-authors include Daniel S. Leventhal, Ning Li, José M. Lora, Starsha Kolodziej, Adam Fisher, Anna Sokolovska, Munira Momin, Rudy Christmas, Michael J. James and Kip A. West. Their work appears in journals such as Molecular Cancer Therapeutics, Journal of Clinical Oncology, Nature Communications and Differentiation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.